Creative and Flexible Structures


Oberland Capital employs a broad array of transaction structures, customized to meet the specific needs of our partners.

We invest across all therapeutic categories, modalities and geographies. Our focus is primarily on commercial-stage and near commercial-stage healthcare products, though in certain cases we invest in earlier stage opportunities.

Oberland Capital’s broad suite of flexible financing solutions includes monetization of royalty streams, acquisition of future product revenues, creation of project-based financing structures, and investments in traditional debt and equity.  Our team excels in developing and implementing novel, non-dilutive transaction structures in situations involving significant complexity.

Our target investment size ranges between $50 million and $300 million, and we can execute significantly larger transactions. With the capacity to invest at meaningful scale, we are well-positioned to support our partners’ organic and inorganic growth.

We have a long-term investment horizon so that our partners can focus on what they do best—successfully develop and commercialize technologies that address medical unmet needs.


  • Royalty Monetizations
  • Royalty-Backed Securities
  • Revenue Interests
  • Traditional Debt
  • Project-Based Structures
  • Hybrid Structures